Ftse Mib
34.228,77
0,71%
DAX
18.430,05
1,42%
S&P 500
5.186,01
0,10%
NASDAQ
16.375,88
0,16%
Bitcoin
63.397,87
0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Merrimack Pharmaceuticals Inc (MACK) Merrimack Pharmaceuticals Inc (MACK) Notizie

Merrimack Pharmaceuticals Inc

MACK
15,05
0,035 (0,23%)
Ultimo aggiornamento: 19:30:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202423:15BWMerrimack Pharmaceuticals Announces Notification of Plan to..
27/3/202421:30BWMerrimack Receives $225 Million Milestone Payment from Ipsen
07/3/202422:42EDGAR2Form 425 - Prospectuses and communications, business..
07/3/202422:39EDGAR2Form 8-K - Current report
07/3/202422:30BWMerrimack Reports Full Year 2023 Financial Results
07/3/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202418:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/3/202422:44EDGAR2Form PRE 14A - Other preliminary proxy statements
14/2/202422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/2/202422:22EDGAR2Form 8-K - Current report
13/2/202422:18BWMerrimack Reports Ipsen Announcement of Approval By The US..
25/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
28/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
11/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202300:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:30BWMerrimack Reports Third Quarter 2023 Financial Results
14/8/202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
09/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:36EDGAR2Form 8-K - Current report
03/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:30BWMerrimack Reports Second Quarter 2023 Financial Results
Apertura: 15,00 Min: 15,00 Max: 15,06
Chiusura: 15,015

La tua Cronologia

NASDAQ
MACK
Merrimack Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network